Renalytix (Reg S) (RENX)

Sector:

Health Care

Index:

FTSE AIM All-Share

123.75p
   
  • Change Today:
    -1.25p
  • 52 Week High: 490.00
  • 52 Week Low: 47.50
  • Currency: UK Pounds
  • Shares Issued: 74.89m
  • Volume: 16,643
  • Market Cap: £92.68m
  • RiskGrade: 348

RENX Overview

RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1931.7% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 39.0 n/a
Pr/Book 2.7  
Latest F'cast
Revenue 99.2% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

RENX Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-18 n/a (0.42) (1.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-19 n/a (7.12) (17.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-20 n/a (10.61) (16.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-21 1.49 (35.79) (43.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-22 2.97 (49.63) (78.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

RENX Company Announcements

Renalytix and Partners Awarded $10 Million Grant 26-Jan-2023 07:00 RNS
Second Price Monitoring Extn 09-Jan-2023 11:05 RNS
Price Monitoring Extension 09-Jan-2023 11:00 RNS

RENX ShareCast News

Renalytix rises on publication of positive evide... 29-Nov-2022 ShareCast
Renalytix reports positive outcomes from Mount S... 10-Jun-2022 ShareCast
Renalytix completes financing to support its gro... 08-Apr-2022 ShareCast

Latest RENX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

RENX Market Data

Currency UK Pounds
Share Price 123.75p
Change Today -1.25p
% Change -1.00 %
52 Week High 490.00
52 Week Low 47.50
Volume 16,643
Shares Issued 74.89m
Market Cap £92.68m
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
3.11% below the market average3.11% below the market average3.11% below the market average3.11% below the market average3.11% below the market average
44.44% above the sector average44.44% above the sector average44.44% above the sector average44.44% above the sector average44.44% above the sector average
Price Trend
50.83% below the market average50.83% below the market average50.83% below the market average50.83% below the market average50.83% below the market average
43.59% below the sector average43.59% below the sector average43.59% below the sector average43.59% below the sector average43.59% below the sector average
Income Not Available
Growth
18.70% above the market average18.70% above the market average18.70% above the market average18.70% above the market average18.70% above the market average
25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average

RENX Dividends

No dividends found

Trades for 31-Jan-2023

Time Volume / Share Price
09:03 33 @ 121.00p
08:59 10 @ 129.50p
08:58 1,600 @ 125.00p
08:12 15,000 @ 124.11p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page